Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
SOPHiA GENETICS SA SOPH
$4.53
-$0.1 (-2.16%)
На 18:04, 12 мая 2023
+32.45%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
307687566.00000000
-
week52high
5.77
-
week52low
1.69
-
Revenue
47560000
-
P/E TTM
-4
-
Beta
0.00000000
-
EPS
-1.24000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 12:00
Описание компании
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | 10 авг 2022 г. |
| Morgan Stanley | Overweight | Overweight | 11 мая 2022 г. |
| Morgan Stanley | Overweight | Overweight | 16 мар 2022 г. |
| Morgan Stanley | Overweight | Overweight | 15 февр 2022 г. |
| Morgan Stanley | Overweight | 17 авг 2021 г. | |
| Morgan Stanley | Overweight | Overweight | 09 ноя 2022 г. |
| Credit Suisse | Neutral | 23 ноя 2022 г. | |
| BTIG | Buy | 03 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference
Business Wire
04 янв 2023 г. в 16:02
BOSTON & LAUSANNE, Switzerland--( BUSINESS WIRE )--SOPHiA GENETICS SA (NASDAQ: SOPH) today announced that Dr. Jurgi Camblong, Chief Executive Officer and Co-Founder, is scheduled to present at the J.P. Morgan 2023 Healthcare Conference on Tuesday, January 10, 2023, at 8:15 a.m. PST in San Francisco.
SOPHiA GENETICS SA (SOPH) Q3 2022 Earnings Call Transcript
Seeking Alpha
12 ноя 2022 г. в 13:31
Start Time: 08:30 January 1, 0000 9:27 AM ET SOPHiA GENETICS SA (NASDAQ:SOPH ) Q3 2022 Earnings Conference Call November 08, 2022, 08:30 AM ET Company Participants Jurgi Camblong - Founder and CEO Ross Muken - CFO Philippe Menu - Chief Medical Officer Jennifer Pottage - Head, IR Conference Call Participants Julia Qin - JPMorgan Kyle Boucher - Cowen Vidyun Bais - BTIG Operator Good morning, everyone, and welcome to the SOPHiA GENETICS Third Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode.
SOPHiA GENETICS SA (SOPH) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research
08 ноя 2022 г. в 09:48
SOPHiA GENETICS SA (SOPH) delivered earnings and revenue surprises of -5.88% and 0.04%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
SOPHiA GENETICS to Participate in Upcoming November Investor Conferences
GlobeNewsWire
04 ноя 2022 г. в 06:49
BOSTON and LAUSANNE, Switzerland, Nov. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today the company will be participating in the following investor conferences.
SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2022 on November 8, 2022
GlobeNewsWire
06 окт 2022 г. в 07:01
BOSTON and GENEVA, Switzerland, Oct. 06, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the third quarter of fiscal 2022 before U.S. markets open on Tuesday, November 8, 2022. SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:30 a.m. EST / 2:30 p.m. CET.